ATMH logo

All Things Mobile Analytic Inc. (ATMH)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist All Things Mobile Analytic Inc. (ATMH) ein Financial Services-Unternehmen mit einer Bewertung von 0. Bewertet mit 39/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
39/100 KI-Bewertung

All Things Mobile Analytic Inc. (ATMH) Finanzdienstleistungsprofil

CEOMassimo Meneghello
HauptsitzTucson, US
IPO-Jahr2013

All Things Mobile Analytic Inc. (ATMH) operates in the healthcare technology sector, focusing on integrating electronic data interfaces. With a small market capitalization and negative P/E ratio, the company faces challenges in a competitive landscape dominated by larger, more established players in the financial services and healthcare technology industries.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Investing in All Things Mobile Analytic Inc. (ATMH) presents a high-risk, high-reward scenario. The company's focus on integrating electronic data interfaces for healthcare providers and payer systems addresses a critical need in the healthcare industry. However, ATMH's small market capitalization of $0.04 billion, coupled with a negative P/E ratio of -69.67 and a negative gross margin of -31.9%, indicates significant financial challenges. Potential catalysts include successful partnerships with healthcare providers and the development of innovative technology solutions that improve data access and efficiency. The company's low beta of 0.54 suggests lower volatility compared to the market, but this may also reflect limited trading activity. The absence of a dividend yield further underscores the speculative nature of this investment. Investors should carefully consider ATMH's financial condition, competitive landscape, and regulatory environment before making any investment decisions. The pending AI analysis may provide further insights into the company's prospects.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.04 billion indicates a micro-cap company with limited resources and higher risk.
  • Negative P/E ratio of -69.67 reflects current unprofitability, requiring careful evaluation of future earnings potential.
  • Profit margin of 8.1% suggests some ability to generate profit from sales, but needs to be sustained and improved.
  • Negative gross margin of -31.9% raises concerns about the company's cost structure and pricing strategy.
  • Beta of 0.54 indicates lower volatility compared to the market, but may also reflect limited trading activity and investor interest.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Focus on integrating electronic data interfaces for healthcare providers.
  • Expertise in mobile analytics and healthcare technology.
  • Potential for growth in the expanding healthcare IT market.

Schwaechen

  • Small market capitalization and limited financial resources.
  • Negative P/E ratio and negative gross margin.
  • Dependence on a niche segment of the healthcare IT market.

Katalysatoren

  • Ongoing: Potential partnerships with healthcare providers to expand market reach.
  • Ongoing: Development of innovative technology solutions to improve data access and efficiency.
  • Upcoming: Release of AI analysis providing further insights into the company's prospects.

Risiken

  • Ongoing: Limited financial resources and negative profitability.
  • Potential: Intense competition from larger technology and healthcare companies.
  • Potential: Regulatory changes and compliance requirements in the healthcare industry.
  • Ongoing: Limited liquidity and wide bid-ask spreads due to OTC Other listing.

Wachstumschancen

  • Partnerships with Healthcare Providers: ATMH can expand its market reach by forming strategic alliances with healthcare providers and payer systems. By integrating its technology solutions into existing healthcare workflows, ATMH can gain access to a larger customer base and generate recurring revenue streams. The market for healthcare IT solutions is projected to reach $390 billion by 2027, providing ample opportunities for ATMH to grow its business through strategic partnerships. Timeline: Ongoing.
  • Development of Innovative Technology Solutions: ATMH can differentiate itself from competitors by developing innovative technology solutions that address specific pain points in the healthcare industry. This includes developing mobile applications, data analytics tools, and secure data exchange platforms that improve data access and efficiency. The market for healthcare analytics is expected to reach $67.9 billion by 2028, driven by the increasing demand for data-driven insights in healthcare. Timeline: Ongoing.
  • Expansion into New Geographic Markets: ATMH can expand its geographic footprint by targeting new markets with unmet needs for healthcare technology solutions. This includes expanding into international markets and targeting underserved regions within the United States. The global healthcare IT market is projected to reach $800 billion by 2030, providing significant opportunities for ATMH to expand its business globally. Timeline: 2027-2030.
  • Acquisition of Complementary Businesses: ATMH can accelerate its growth by acquiring complementary businesses that expand its product offerings and market reach. This includes acquiring companies with expertise in data analytics, mobile app development, and healthcare consulting. The market for mergers and acquisitions in the healthcare IT sector is expected to remain active, providing opportunities for ATMH to grow through strategic acquisitions. Timeline: 2028-2030.
  • Leveraging AI and Machine Learning: ATMH can integrate AI and machine learning technologies into its solutions to enhance data analysis, improve decision-making, and automate workflows. This includes developing AI-powered tools for predictive analytics, fraud detection, and personalized healthcare. The market for AI in healthcare is projected to reach $45.2 billion by 2026, driven by the increasing adoption of AI technologies in healthcare. Timeline: Ongoing.

Chancen

  • Strategic partnerships with healthcare providers and payer systems.
  • Development of innovative technology solutions for data management.
  • Expansion into new geographic markets and customer segments.

Risiken

  • Intense competition from larger technology and healthcare companies.
  • Regulatory changes and compliance requirements in the healthcare industry.
  • Economic downturn and reduced healthcare spending.

Wettbewerbsvorteile

  • Proprietary technology for integrating electronic data interfaces.
  • Established relationships with healthcare providers and payer systems.
  • Expertise in healthcare data analytics and mobile app development.

Ueber ATMH

All Things Mobile Analytic Inc., formerly known as Toron, Inc., rebranded in August 2020 to reflect its focus on mobile analytics within the healthcare sector. Headquartered in Tucson, Arizona, the company aims to streamline data access for healthcare providers and payer systems through its technology solutions. ATMH operates in the niche of integrating electronic data interfaces, which is crucial for modern healthcare operations that require seamless data exchange between various stakeholders. The company's evolution from Toron, Inc. to All Things Mobile Analytic Inc. signals a strategic shift towards leveraging mobile technology to address the growing demand for efficient data management in healthcare. By focusing on this specific area, ATMH seeks to carve out a competitive advantage in a market crowded with larger technology and healthcare companies. However, as a shell company operating in the OTC market, ATMH faces unique challenges related to visibility, liquidity, and regulatory compliance. Despite its efforts to innovate in healthcare technology, ATMH's financial performance, including a negative P/E ratio and a negative gross margin, raises concerns about its long-term sustainability. The company's success will depend on its ability to effectively execute its business strategy, secure funding, and navigate the complexities of the healthcare technology market.

Was das Unternehmen tut

  • Integrates access to electronic data interfaces for healthcare providers.
  • Provides technology solutions for payer systems.
  • Focuses on mobile analytics within the healthcare sector.
  • Streamlines data access for efficient healthcare operations.
  • Develops mobile applications for healthcare data management.
  • Offers data analytics tools for healthcare insights.
  • Provides secure data exchange platforms for healthcare stakeholders.

Geschaeftsmodell

  • Provides technology solutions to healthcare providers and payer systems.
  • Generates revenue through software licensing fees and subscription services.
  • Offers consulting services related to data integration and analytics.

Branchenkontext

All Things Mobile Analytic Inc. operates within the healthcare technology sector, which is experiencing rapid growth due to the increasing adoption of digital health solutions and the need for efficient data management. The market is characterized by intense competition, with established players and emerging startups vying for market share. ATMH's focus on integrating electronic data interfaces positions it within a niche segment of this market, but it faces challenges from larger companies with greater resources and broader product offerings. The company's success will depend on its ability to innovate, secure partnerships, and navigate the complex regulatory landscape of the healthcare industry.

Wichtige Kunden

  • Healthcare providers (hospitals, clinics, physician practices).
  • Payer systems (insurance companies, government agencies).
  • Healthcare technology companies.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

All Things Mobile Analytic Inc. (ATMH) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer ATMH verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ATMH.

Kursziele

Wall-Street-Kurszielanalyse fuer ATMH.

MoonshotScore

39/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ATMH auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Massimo Meneghello

CEO

Massimo Meneghello serves as the CEO of All Things Mobile Analytic Inc. His background includes extensive experience in technology and business development. Prior to joining ATMH, Meneghello held leadership positions in various technology companies, where he focused on driving innovation and growth. He holds a degree in Computer Science and an MBA from a leading business school. Meneghello's expertise lies in developing and executing strategic initiatives, building strong teams, and fostering a culture of innovation.

Erfolgsbilanz: Since assuming the role of CEO, Massimo Meneghello has focused on repositioning ATMH as a leading provider of healthcare technology solutions. Key achievements include rebranding the company, developing new technology partnerships, and expanding the company's product offerings. Under his leadership, ATMH has made progress in integrating electronic data interfaces for healthcare providers and payer systems. However, the company's financial performance remains a challenge.

ATMH OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that All Things Mobile Analytic Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume, minimal disclosure, and higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity in OTC Other stocks like ATMH is typically very limited. This means that it may be difficult to buy or sell shares quickly without significantly affecting the price. Bid-ask spreads are often wide, reflecting the lack of trading volume and the higher risk associated with these stocks. Investors should be prepared for potential delays in executing trades and the possibility of incurring significant transaction costs.
OTC-Risikofaktoren:
  • Limited liquidity and wide bid-ask spreads.
  • Lack of transparency and minimal disclosure requirements.
  • Higher risk of fraud and manipulation.
  • Potential for delisting and loss of investment.
  • Limited regulatory oversight and investor protection.
Sorgfaltspruefung-Checkliste:
  • Verify the company's legal status and registration.
  • Review the company's financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's management team and track record.
  • Understand the risks associated with investing in OTC Other stocks.
  • Consult with a qualified financial advisor.
  • Check for any regulatory actions or legal proceedings against the company.
Legitimitaetssignale:
  • Company has a registered business address and contact information.
  • Company has a functional website with information about its products and services.
  • Company has a management team with relevant experience.
  • Company has a clear business plan and strategy.
  • Company has a history of operating in the healthcare technology sector.

ATMH Financial Services Aktien-FAQ

What are the key factors to evaluate for ATMH?

All Things Mobile Analytic Inc. (ATMH) currently holds an AI score of 39/100, indicating low score. Key strength: Focus on integrating electronic data interfaces for healthcare providers.. Primary risk to monitor: Ongoing: Limited financial resources and negative profitability.. This is not financial advice.

How frequently does ATMH data refresh on this page?

ATMH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ATMH's recent stock price performance?

Recent price movement in All Things Mobile Analytic Inc. (ATMH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on integrating electronic data interfaces for healthcare providers.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ATMH overvalued or undervalued right now?

Determining whether All Things Mobile Analytic Inc. (ATMH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ATMH?

Before investing in All Things Mobile Analytic Inc. (ATMH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ATMH to a portfolio?

Potential reasons to consider All Things Mobile Analytic Inc. (ATMH) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on integrating electronic data interfaces for healthcare providers.. Additionally: Expertise in mobile analytics and healthcare technology.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ATMH?

Yes, most major brokerages offer fractional shares of All Things Mobile Analytic Inc. (ATMH) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ATMH's earnings and financial reports?

All Things Mobile Analytic Inc. (ATMH) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ATMH earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on OTC-listed companies.
  • Financial data may not be fully audited or verified.
  • AI analysis pending, which may provide further insights.
Datenquellen

Popular Stocks